Commodore Capital LP Relay Therapeutics, Inc. Transaction History
Commodore Capital LP
- $1.57 Billion
- Q3 2025
A detailed history of Commodore Capital LP transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Commodore Capital LP holds 17,000,000 shares of RLAY stock, worth $113 Million. This represents 5.66% of its overall portfolio holdings.
Number of Shares
17,000,000
Previous 13,350,000
27.34%
Holding current value
$113 Million
Previous $46.2 Million
92.12%
% of portfolio
5.66%
Previous 4.31%
Shares
2 transactions
Others Institutions Holding RLAY
# of Institutions
215Shares Held
168MCall Options Held
714KPut Options Held
14.9K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$185 Million1.1% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct14.8MShares$97.8 Million0.15% of portfolio
-
Casdin Capital, LLC New York, NY11.3MShares$75.1 Million8.07% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$69.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.4MShares$62.2 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $796M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...